Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors
Search in posts
Search in pages
Filter by Categories
BENCH-PRESS : Original Article
BEYOND CLINICAL ONCOLOGY : Original Article
Brainteaser
BREAST CANCER : Original Article
BREAST CANCERS Original Article
Brief Commentary MEDic LAWgic Section
Brief Report, Public Health
CANCER EPIDEMIOLOGY: Original Article
CANCER SURGERY : Original Article
Cardio-Oncology
Case Report
Case Series, Haematological
CLINICAL TRIAL : Original Article
COLORECTAL CANCER : Original Article
COMMENTARY
Consensus
Consensus Recommendations, Head Neck
Controversy
Corrigendum
Diagnostic Dilemma
Drug Review
DRUG REVIEW : Review Article
Editorial
Editorial Commentary
Editorial: Memoir
Erratum
ESOPHAGEAL CANCER : Original Article
FEMALE REPRODUCTIVE TRACT TUMORS : Original Article
GCT Review Article
GENITOURINARY : Original Article
GI CANCER Original Article
HEAD AND NECK CANCER : Original Article
HEAD AND NECK CANCER : Review Article
HEAD AND NECK CANCERS : Original Article
HISTOPATHOLOGY IN ONCOLOGY : Original Article
In Response
Letter to Editor
Letter to Editor, Breast
Letter to Editor: Oral Carcinoma
Letter to the Editor
Letters to Editor
Letters to the Editor
LEUKEMIA : Original Article
LEUKEMIAS : Original Article
LUNG CANCER: Original Article
METRONOMIC THERAPY IN AML : Original Article
METRONOMIC THERAPY IN HEAD AND NECK CANCERS : Original Article
METRONOMIC THERAPY IN LUNG CANCER : Original Article
METRONOMIC THERAPY IN OVARIAN CANCER : Original Article
Mini Commentary
Mini Symposium - FNAC VERSUS CORE BIOPSY: Editorial
Mini Symposium - FNAC VERSUS CORE BIOPSY: Original Article
Mini Symposium - RT DOSIMETRY AND FRACTIONATION: Editorial
Mini Symposium - RT DOSIMETRY AND FRACTIONATION: Original Article
Mini Symposium on Changing Landscape: Brief Article
Mini Symposium on Changing Landscape: Editorial
Mini Symposium on Changing Landscape: Original Article
Mini Symposium on CML
Mini Symposium on Supportive Care: Original Article
MINI SYMPOSIUM: HEAD AND NECK CANCER : Editorial
MINI SYMPOSIUM: HEAD AND NECK CANCER : Original Article
MINI SYMPOSIUM: HEAD AND NECK CANCER : Review Article
MINI SYMPOSIUM: HEAD AND NECK ONCOLOGY: Original Article
MINI SYMPOSIUM: MOLECULAR ONCOLOGY: Original Article
MINI SYMPOSIUM: PEDIATRIC ONCOLOGY: Original Article
MISCELLANEOUS : Original Article
MOLECULAR ONCOLOGY : Original Article
MULTIPLE CANCERS Original Article
MYELODYSPLASTIC SYNDROME : Review Article
MYELOID LEUKEMIA : Original Article
NEURO ONCOLOGY : Review Article
NEURO-ONCOLOGY : Original Article
None
Notice of Retraction
OESOPHAGEAL CANCER : Original Article
Oncology Reflections
Original Article
Original Article : Bone & Soft Tissue Tumors
ORIGINAL ARTICLE : Bone and Soft Tissue Sarcomas
ORIGINAL ARTICLE : Breast Cancer
Original Article : Breast Cancers
Original Article : Gastro-intestinal & Hepatobiliary Cancers
Original Article : Genitourinary & Gynecological Cancers
ORIGINAL ARTICLE : GI Cancer
ORIGINAL ARTICLE : GI Oncology
ORIGINAL ARTICLE : Gynaecologic Oncology
Original Article : Head and Neck Cancers
ORIGINAL ARTICLE : Hematolymphoid
Original Article : Leukemia & Lymphoma
ORIGINAL ARTICLE : Leukemia and Lymphoma
ORIGINAL ARTICLE : Melanoma and Skin Cancer
Original Article : Pediatric and Adolescent Cancers
ORIGINAL ARTICLE : SAARC Selection
ORIGINAL ARTICLE : Supportive Care and Others
Original Article, Breast
Original Article, Gastrointestinal
Original Article, Gynaecological
Original Article, Head Neck
Original Article, Neurological
Original Article, Public Health
Original Article: Bladder Cancer
Original Article: Bone and Soft Tissue Cancers
Original Article: Bone and Soft Tissue Tumor
ORIGINAL ARTICLE: Bone and Soft Tissue Tumors
Original Article: Brain Tumor
ORIGINAL ARTICLE: Brain Tumors
Original Article: Cancer Epidemiology and Screening
Original Article: Cancer Epidemiology, Screening and diagnosis
ORIGINAL ARTICLE: Diagnostics in Oncology
ORIGINAL ARTICLE: Epidemiology of Cancer and Cancer Screening
ORIGINAL ARTICLE: Gastro-intestinal & Hepatobiliary Cancer
Original Article: Gastrointestinal Cancer
Original Article: Genito Urinary Cancer
ORIGINAL ARTICLE: Genitourinary & Gynaecological Cancer
Original Article: Genitourinary Cancer
ORIGINAL ARTICLE: Genitourinary Cancers
Original Article: Geriatric Oncology
ORIGINAL ARTICLE: GI Cancers
Original Article: GI Cancers and Hepatobilliary Malignancies
ORIGINAL ARTICLE: Gynaecologic Cancers
ORIGINAL ARTICLE: Gynaecological Cancer
ORIGINAL ARTICLE: Gynaecological Cancers
Original Article: Gynecological Cancer
ORIGINAL ARTICLE: Head and Neck Cancer
ORIGINAL ARTICLE: Hematolymphoid Malignancies
Original Article: Hematolymphoid Malignancy
Original Article: Hepatobiliary Cancer
ORIGINAL ARTICLE: Immuno - Oncology
Original Article: Leukemia -Lymphoma and Myeloma
ORIGINAL ARTICLE: Leukemia, Lymphoma & Plasma Cell Disorder
Original Article: Lung Cancer
ORIGINAL ARTICLE: Lung Cancers
ORIGINAL ARTICLE: Neuroendocrine Tumors
Original Article: Paediatric Cancer
ORIGINAL ARTICLE: Palliative Care
ORIGINAL ARTICLE: Pediatric Oncology
ORIGINAL ARTICLE: Sarcomas
ORIGINAL ARTICLE: Sarcomas and Skin Cancer
Original Article: Skin Cancer
Original Article: Supportive and Palliative Care
Original Article: Supportive and Palliative Care in Cancer
ORIGINAL ARTICLE: Supportive Care
Original Research Article
PEDIATRIC ONCOLOGY : Original Article
PEDIATRIC SECTION: Editorial
PEDIATRIC SECTION: Original Article
Pictorial CME, Haematological
Poetry in Oncology
Position Paper
QUEST FOR AN ANTIDOTE TO RADIATION TOXICITY : Editorial
QUEST FOR AN ANTIDOTE TO RADIATION TOXICITY : Original Article
RCC Practical Consensus Recommendations
Regional Article
Review Article
Review Article, Breast
Review Article, Haematological
Review Article, International
SARCOMA : Original Article
SARCOMA Review Article
SOFT TISSUE SARCOMA : Original Article
South Asia update
SOUTH ASIAN UPDATE : An update
SOUTH ASIAN UPDATE : Original Article
TABACCO, THE MENACE : Original Article
THE CUTTING EDGE OF RADIOTHERAPEUTICS : Editorial
THE CUTTING EDGE OF RADIOTHERAPEUTICS : Original Article
THE GREAT DEBATE: Against HPV vaccine in cervical cancer
THE GREAT DEBATE: AGAINST IMATINIB AS THE FIRST LINE TKI CHOICE FOR CML
THE GREAT DEBATE: Editorial-HPV vaccine in cervical cancer
THE GREAT DEBATE: For HPV vaccine in cervical cancer
THE GREAT DEBATE: FOR IMATINIB AS THE FIRST LINE TKI CHOICE FOR CML
THE GREY-HAIRED CANCER PATIENT: Editorial
THE GREY-HAIRED CANCER PATIENT: Original Article
THE SKILLFUL SCALPEL: Editorial
THE SKILLFUL SCALPEL: Original Article
THE WAR ON MICROBES: Editorial
THE WAR ON MICROBES: Original Article
THROUGH THE MICROSCOPE : Original Article
THROUGH THE MICROSCOPE: Editorial
TREATMENT TOXICITY : Original Article
TRENDS IN HORMONAL THERAPY IN PROSTATE CANCER: Review Article
URO-ONCOLOGY : Original Article
View Point
Viewpoint
Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors
Search in posts
Search in pages
Filter by Categories
BENCH-PRESS : Original Article
BEYOND CLINICAL ONCOLOGY : Original Article
Brainteaser
BREAST CANCER : Original Article
BREAST CANCERS Original Article
Brief Commentary MEDic LAWgic Section
Brief Report, Public Health
CANCER EPIDEMIOLOGY: Original Article
CANCER SURGERY : Original Article
Cardio-Oncology
Case Report
Case Series, Haematological
CLINICAL TRIAL : Original Article
COLORECTAL CANCER : Original Article
COMMENTARY
Consensus
Consensus Recommendations, Head Neck
Controversy
Corrigendum
Diagnostic Dilemma
Drug Review
DRUG REVIEW : Review Article
Editorial
Editorial Commentary
Editorial: Memoir
Erratum
ESOPHAGEAL CANCER : Original Article
FEMALE REPRODUCTIVE TRACT TUMORS : Original Article
GCT Review Article
GENITOURINARY : Original Article
GI CANCER Original Article
HEAD AND NECK CANCER : Original Article
HEAD AND NECK CANCER : Review Article
HEAD AND NECK CANCERS : Original Article
HISTOPATHOLOGY IN ONCOLOGY : Original Article
In Response
Letter to Editor
Letter to Editor, Breast
Letter to Editor: Oral Carcinoma
Letter to the Editor
Letters to Editor
Letters to the Editor
LEUKEMIA : Original Article
LEUKEMIAS : Original Article
LUNG CANCER: Original Article
METRONOMIC THERAPY IN AML : Original Article
METRONOMIC THERAPY IN HEAD AND NECK CANCERS : Original Article
METRONOMIC THERAPY IN LUNG CANCER : Original Article
METRONOMIC THERAPY IN OVARIAN CANCER : Original Article
Mini Commentary
Mini Symposium - FNAC VERSUS CORE BIOPSY: Editorial
Mini Symposium - FNAC VERSUS CORE BIOPSY: Original Article
Mini Symposium - RT DOSIMETRY AND FRACTIONATION: Editorial
Mini Symposium - RT DOSIMETRY AND FRACTIONATION: Original Article
Mini Symposium on Changing Landscape: Brief Article
Mini Symposium on Changing Landscape: Editorial
Mini Symposium on Changing Landscape: Original Article
Mini Symposium on CML
Mini Symposium on Supportive Care: Original Article
MINI SYMPOSIUM: HEAD AND NECK CANCER : Editorial
MINI SYMPOSIUM: HEAD AND NECK CANCER : Original Article
MINI SYMPOSIUM: HEAD AND NECK CANCER : Review Article
MINI SYMPOSIUM: HEAD AND NECK ONCOLOGY: Original Article
MINI SYMPOSIUM: MOLECULAR ONCOLOGY: Original Article
MINI SYMPOSIUM: PEDIATRIC ONCOLOGY: Original Article
MISCELLANEOUS : Original Article
MOLECULAR ONCOLOGY : Original Article
MULTIPLE CANCERS Original Article
MYELODYSPLASTIC SYNDROME : Review Article
MYELOID LEUKEMIA : Original Article
NEURO ONCOLOGY : Review Article
NEURO-ONCOLOGY : Original Article
None
Notice of Retraction
OESOPHAGEAL CANCER : Original Article
Oncology Reflections
Original Article
Original Article : Bone & Soft Tissue Tumors
ORIGINAL ARTICLE : Bone and Soft Tissue Sarcomas
ORIGINAL ARTICLE : Breast Cancer
Original Article : Breast Cancers
Original Article : Gastro-intestinal & Hepatobiliary Cancers
Original Article : Genitourinary & Gynecological Cancers
ORIGINAL ARTICLE : GI Cancer
ORIGINAL ARTICLE : GI Oncology
ORIGINAL ARTICLE : Gynaecologic Oncology
Original Article : Head and Neck Cancers
ORIGINAL ARTICLE : Hematolymphoid
Original Article : Leukemia & Lymphoma
ORIGINAL ARTICLE : Leukemia and Lymphoma
ORIGINAL ARTICLE : Melanoma and Skin Cancer
Original Article : Pediatric and Adolescent Cancers
ORIGINAL ARTICLE : SAARC Selection
ORIGINAL ARTICLE : Supportive Care and Others
Original Article, Breast
Original Article, Gastrointestinal
Original Article, Gynaecological
Original Article, Head Neck
Original Article, Neurological
Original Article, Public Health
Original Article: Bladder Cancer
Original Article: Bone and Soft Tissue Cancers
Original Article: Bone and Soft Tissue Tumor
ORIGINAL ARTICLE: Bone and Soft Tissue Tumors
Original Article: Brain Tumor
ORIGINAL ARTICLE: Brain Tumors
Original Article: Cancer Epidemiology and Screening
Original Article: Cancer Epidemiology, Screening and diagnosis
ORIGINAL ARTICLE: Diagnostics in Oncology
ORIGINAL ARTICLE: Epidemiology of Cancer and Cancer Screening
ORIGINAL ARTICLE: Gastro-intestinal & Hepatobiliary Cancer
Original Article: Gastrointestinal Cancer
Original Article: Genito Urinary Cancer
ORIGINAL ARTICLE: Genitourinary & Gynaecological Cancer
Original Article: Genitourinary Cancer
ORIGINAL ARTICLE: Genitourinary Cancers
Original Article: Geriatric Oncology
ORIGINAL ARTICLE: GI Cancers
Original Article: GI Cancers and Hepatobilliary Malignancies
ORIGINAL ARTICLE: Gynaecologic Cancers
ORIGINAL ARTICLE: Gynaecological Cancer
ORIGINAL ARTICLE: Gynaecological Cancers
Original Article: Gynecological Cancer
ORIGINAL ARTICLE: Head and Neck Cancer
ORIGINAL ARTICLE: Hematolymphoid Malignancies
Original Article: Hematolymphoid Malignancy
Original Article: Hepatobiliary Cancer
ORIGINAL ARTICLE: Immuno - Oncology
Original Article: Leukemia -Lymphoma and Myeloma
ORIGINAL ARTICLE: Leukemia, Lymphoma & Plasma Cell Disorder
Original Article: Lung Cancer
ORIGINAL ARTICLE: Lung Cancers
ORIGINAL ARTICLE: Neuroendocrine Tumors
Original Article: Paediatric Cancer
ORIGINAL ARTICLE: Palliative Care
ORIGINAL ARTICLE: Pediatric Oncology
ORIGINAL ARTICLE: Sarcomas
ORIGINAL ARTICLE: Sarcomas and Skin Cancer
Original Article: Skin Cancer
Original Article: Supportive and Palliative Care
Original Article: Supportive and Palliative Care in Cancer
ORIGINAL ARTICLE: Supportive Care
Original Research Article
PEDIATRIC ONCOLOGY : Original Article
PEDIATRIC SECTION: Editorial
PEDIATRIC SECTION: Original Article
Pictorial CME, Haematological
Poetry in Oncology
Position Paper
QUEST FOR AN ANTIDOTE TO RADIATION TOXICITY : Editorial
QUEST FOR AN ANTIDOTE TO RADIATION TOXICITY : Original Article
RCC Practical Consensus Recommendations
Regional Article
Review Article
Review Article, Breast
Review Article, Haematological
Review Article, International
SARCOMA : Original Article
SARCOMA Review Article
SOFT TISSUE SARCOMA : Original Article
South Asia update
SOUTH ASIAN UPDATE : An update
SOUTH ASIAN UPDATE : Original Article
TABACCO, THE MENACE : Original Article
THE CUTTING EDGE OF RADIOTHERAPEUTICS : Editorial
THE CUTTING EDGE OF RADIOTHERAPEUTICS : Original Article
THE GREAT DEBATE: Against HPV vaccine in cervical cancer
THE GREAT DEBATE: AGAINST IMATINIB AS THE FIRST LINE TKI CHOICE FOR CML
THE GREAT DEBATE: Editorial-HPV vaccine in cervical cancer
THE GREAT DEBATE: For HPV vaccine in cervical cancer
THE GREAT DEBATE: FOR IMATINIB AS THE FIRST LINE TKI CHOICE FOR CML
THE GREY-HAIRED CANCER PATIENT: Editorial
THE GREY-HAIRED CANCER PATIENT: Original Article
THE SKILLFUL SCALPEL: Editorial
THE SKILLFUL SCALPEL: Original Article
THE WAR ON MICROBES: Editorial
THE WAR ON MICROBES: Original Article
THROUGH THE MICROSCOPE : Original Article
THROUGH THE MICROSCOPE: Editorial
TREATMENT TOXICITY : Original Article
TRENDS IN HORMONAL THERAPY IN PROSTATE CANCER: Review Article
URO-ONCOLOGY : Original Article
View Point
Viewpoint
View/Download PDF

Translate this page into:

Original Article
14 (
02
); 333-340
doi:
10.1055/s-0044-1791224

Novel Nomogram for Prediction of Lymph Node Metastases from Buccal Mucosa Squamous Carcinoma Using Histological Parameters

Department of Surgical Oncology, Sri Ram Cancer & Superspeciality Centre (SRCC), Mahatma Gandhi Medical College & Hospital, Mahatma Gandhi University of Medical Sciences & Technology (MGUMST), Jaipur, Rajasthan, India
Division of Biostatistics, Department of Community Medicine, Mahatma Gandhi Medical College & Hospital, Mahatma Gandhi University of Medical Sciences & Technology (MGUMST), Jaipur, Rajasthan, India
Department of Clinical Hematology, Sri Ram Cancer & Superspeciality Centre (SRCC), Mahatma Gandhi Medical College & Hospital, Mahatma Gandhi University of Medical Sciences & Technology (MGUMST), Jaipur, Rajasthan, India
Author image
Corresponding author: Mohinder Viswanath, MBBS, MS, MCh, Sitapura, Jaipur 302022, Rajasthan, India. mohinderviswanath@gmail.com
Licence
This is an open-access article distributed under the terms of the Creative Commons Attribution-Non Commercial-Share Alike 4.0 License, which allows others to remix, transform, and build upon the work non-commercially, as long as the author is credited and the new creations are licensed under the identical terms.
Disclaimer:
This article was originally published by Thieme Medical and Scientific Publishers Pvt. Ltd. and was migrated to Scientific Scholar after the change of Publisher.

Abstract

Abstract

Objective

The aim of the study was to construct a nomogram that is easily reproducible, accurate, and cost-effective in predicting cervical lymph nodal metastasis in buccal mucosa cancer.

Methodology

Patients who underwent radical resection of a primary tumor of the buccal mucosa with neck dissection were enrolled. Clinical characteristics independently associated with lymph nodal metastasis in multivariate analyses were adopted to build the model.

Results

Patients who underwent surgery (January 2021–December 2021) were included as the model development cohort (n = 127). Depth of invasion, perineural invasion, lymphovascular invasion, and the worst pattern of invasion were independent predictors of lymph nodal metastasis. The nomogram model based on these four predictors showed good discrimination accuracy in percentage prediction of lymph nodal metastasis.

Conclusion

This study proposes a simple predictive model for the risk of nodal metastasis in buccal mucosa squamous cell cancer. The study has strength that, it is based on a large sample, proposed model being simple size, and based on parameters empirically supported as well as established in literature, easy to use in routine clinical practice, and cost-effective.

Keywords

PubMed

Introduction

At present, oral cancer is risk stratified based on the tumor, nodes, metastases (TNM) system of classification proposed by the American Joint Committee on Cancer 8th edition. Nodal metastasis is the single most important prognostic factor and decreases survival by 50%.12 TNM system is being used to predict prognosis and the need for adjuvant treatment. The management of clinically negative neck nodes (N0) poses a significant challenge for surgeons, as there are no reliable parameters to predict occult metastasis. To identify patients who are likely to have occult nodal metastases, several parameters are evaluated, these are radiological in the form of computed tomography (CT) scan, ultrasound (USG), magnetic resonance imaging (MRI), whole-body positron emission tomography-CT, and image-guided fine-needle aspiration cytology (FNAC) from neck nodes, and histopathological like tumor differentiation, perineural invasion (PNI), lymphovascular invasion (LVI), the worst pattern of invasion (WPOI), and depth of invasion (DOI). These all have been previously studied but were not successful. Of late, studies are showing the use of sentinel lymph node biopsy in oral cavity cancer for predicting nodal metastasis which has a sensitivity of 86%.3 On comparing elective versus therapeutic neck dissection, it was found that elective neck dissection was significantly better in overall survival and disease-free survival and supraomohyoid neck dissection has been accepted worldwide as a technique of prophylactic neck dissection for high-risk clinical N0.4 There is a need for predicting the nodal and distal spread of disease, possibly changing the strategy of cancer treatment. This poses a clinical challenge in determining the extent of neck dissection as it is associated with functional side effects such as neck pain, fibrosis, and shoulder dysfunction.5 There is no definite method to find nodal metastasis in carcinoma of buccal mucosa preoperatively. We used method to find nodal metastasis with routine pathological parameters. The objective of the study was to construct a nomogram that is an easily available, accurate, and cost-effective marker in predicting cervical lymph nodal metastasis in buccal mucosa squamous cell carcinoma.

Material and Methods

This study was conducted in the department of surgical oncology at a tertiary care cancer hospital of northwest India after getting ethical committee clearance. It is a prospective observational study from January 2021 to December 2021.

Methodology: Inclusion criteria—All biopsy-proven nonmetastatic invasive squamous cell carcinoma with epicenter in the buccal mucosa.

Patient with an ulcer over buccal mucosa but biopsy negative for malignancy, noninvasive squamous cell carcinoma or nonsquamous cell carcinoma of buccal mucosa, and other subsites, and patient with distant metastatic disease or any previous treatment of any form (surgery radiation or chemotherapy) and coexisting malignancy were excluded.

Patients of both sexes, all ages, presenting with carcinoma of oral cavity who were subsequently planned for surgical treatment were included in the study. Data were evaluated with respect to subsite, T stage of cancer, tumor grading, LVI and PNI by preoperative clinical findings, radiological findings, and histopathological evaluations of the resected specimen and correlated with nodal spread in the neck with respect to the number of nodes, level of spread, and size of nodes.

Total oral cavity case cancer operated (n = 316)

FI2471935-5

127 were enrolled in the study

189 were excluded due to noninvasive squamous cell carcinoma or nonsquamous cell carcinoma of buccal mucosa and other subsites. Patient with distant metastatic disease or any previous treatment of any form

The surgical specimen was processed as per the College of American Pathologist protocol.

Size of tumor: The greatest dimension is taken into consideration.

The DOI is calculated as the distance between the basal membrane and the deepest point of the stromal invasion measured in millimeters (mm).

LVI was defined when a clear pattern of tumor cells within lymphatic, venous, or arterial vessels was identified.

The perineural spread was defined as a clear perineural or neural invasion by tumor cells.

WPOI: It is an important prognostic marker and has five types; for better statistical analysis, we have clubbed 1, 2, and 3 to one group and 4 and 5 to another group.

Grades of tumor: Divided into well-differentiated, moderately differentiated, and poorly differentiated according to border classification.

Statistical Analysis

The statistical analysis was performed using SPSS software (version 26, SPSS Inc., Chicago, Illinois, United States), STATA (version 14.0), and “R” (version 4.0.3). The descriptive statistics for categorical data were given by frequency with percentage and comparison was carried out by using the chi-square test/Fisher's exact test. The receiver operating characteristic (ROC) curves along with area under the curve (AUC) were used to assess the diagnostic ability of DOI for the presence of lymph node metastasis. Sensitivity, specificity, along with positive predictive value (PPV), negative predictive value (NPV), and misclassification rate were assessed. A simple univariate logistic regression was followed by multiple binary logistic regression using significant predictors. The Hosmer–Lemeshow goodness of fit test statistic was performed to test if the model fit of the model was good. An ROC probability curve for the predictive probability of the outcome (lymph node metastasis) based on the multivariable logistic regression model was plotted. Nomogram was constructed for the classification of lymph nodes metastasis based on the logistic regression model. All the statistical tests were performed at 5% level of significance and a p-value of less than 0.05 was considered statistically significant.

Result

Out of 127 study population, 113 (89.0%) were males and 14 (11.0%) were females. Majority in these patients were of stage T2 41 (32.3%) and T4 44 (34.6%). LVI was seen in 15 (11.8%) patients, while PNI in 8 (6.3%). Patients with WPOI 1, 2, and 3 and 4 and 5 were 73 (57.5%) and 54 (42.5%), respectively. Out of 127 study population, metastatic lymph nodes were present in 54 (42.5%) patients and 75 (59.1%) of the patients had > 7.50 mm DOI.

Out of 127 study population, 73 (57.5%) had no lymph nodal metastasis while 54 (42.5%) had lymph nodal metastasis (Table 1). Out of 73 who had no cervical nodal metastasis, 69 (94.5%) were males and 4 (5.5%) were females. Out of 54 who had cervical metastasis, 44 (81.5%) were males and 10 (18.5%) were females, p-value (0.020) is significant.

Table 1
Association between clinical parameters and presence of metastatic lymph node

Variables

Metastatic Lymph node

p-Value

Nonmetastatic lymph nodes

(n = 73)

Metastatic lymph node

(n = 54)

n (%)

n (%)

Gender

Male

69 (94.5)

44 (81.5)

0.020

Female

4 (5.5)

10 (18.5)

Size of the tumor (T)

T1

12 (16.4)

4 (7.4)

0.139

T2

27 (37.0)

14 (25.9)

T3

13 (17.8)

13 (24.1)

T4

21 (28.8)

23 (42.6)

Lymphovascular invasion

Not seen

70 (95.9)

42 (77.8)

0.002

Seen

3 (4.1)

12 (22.2)

Perineural invasion

Not seen

72 (98.6)

47 (87.0)

0.008

Seen

1 (1.4)

7 (13.0)

Worst pattern of invasion

1, 2, 3

49 (67.1)

24 (44.4)

0.010

4 and 5

24 (32.9)

30 (55.6)

Depth of invasion

< 7.50 mm

37 (50.7)

15 (27.8)

0.009

> 7.50 mm

36 (49.3)

39 (72.2)

Out of 73 who had no cervical nodal metastasis LVI was seen in 3 (4.1%) and out of 54 who had cervical metastasis LVI was seen in 12 (22.2%). p-Value (0.002) is significant.

In patients with no cervical nodal metastasis (73), PNI was seen in 1 (1.4%) and in patients with cervical metastasis (54), PNI was seen in 7 (13.0%). p-Value (0.008) is significant.

In patients with no cervical nodal metastasis (73), grade 4 and 5 WPOI was seen in 24 (32.9%) and in patients with cervical metastasis (54), grade 4 and 5 WPOI was seen in 30 (55.6%). p-Value (0.010) is significant.

Out of 73 who had no cervical nodal metastasis DOI > 7.5 mm was seen in 36 (49.3%) and out of 54 who had cervical metastasis DOI > 7.5 mm was seen in 39 (72.2%). p-Value (0.009) is significant.

The univariate logistic regression analysis was performed to ascertain the strength of association of each clinical parameter for the presence of lymph node metastasis (Table 2). The risk of lymph node metastasis was almost fourfold (odds ratio [OR] = 3.92; 95% confidence interval [CI]: 1.16–13.17) among females relative to males.

Table 2
Strength of univariate associations between each characteristic and presence of lymph node metastasis

Variables

OR (95% CI)

p-Value

Gender

Female

3.92 (1.16–13.17)

0.028

Male (Ref)

Size of the tumor (T)

T2

1.56 (0.42–5.72)

0.506

T3

3.00 (0.76–11.78)

0.115

T4

3.29 (0.92–11.78)

0.068

T1 (Ref)

Lymphovascular invasion

Seen

6.67 (1.78–24.99)

0.005

Not seen (Ref)

Perineural invasion

Seen

10.72 (1.28–89.99)

0.029

Not seen (Ref)

1 (1.4)

Worst pattern of invasion

4 and 5

2.55 (1.24–5.27)

0.011

3 (Ref)

24 (32.9)

Depth of invasion

> 7.50 mm

2.67 (1.26–5.67)

0.010

< 7.50 mm (Ref)

Abbreviations: CI, confidence interval; OR, odds ratio.

Though the risk of lymph node metastasis to tumor size T1 was more than 1 for each tumor size T2, T3, and T4, but statistically these were insignificant (p > 0.05).

The risk of lymph node metastasis was 6.67 times (95% CI: 1.78–24.99) higher in patient with LVI in comparison with no LVI.

The risk of lymph nodal metastasis was 10 times (OR = 10.72; 95% CI: 1.28–89.99) higher in patient with PNI in comparison with no PNI.

The risk of lymph nodal metastasis was 2.5 times more (OR = 2.55; 95% CI: 1.24–5.27) higher in patient with WPOI 4 and 5 in comparison with WPOI 1, 2, and 3.

The risk of lymph node metastasis was more than 2.5 times (OR = 2.67; 95% CI: 1.26–5.67) higher in patients with DOI of > 7.50 mm relative to those of DOI < 7.50 mm.

Univariate analysis revealed female gender, LVI positivity, PNI positivity, 4 and 5 WPOI, and increased DOI were associated with significant p-value in the prediction of lymph nodal metastasis.

<insert Table 3 here>

Table 3
Diagnostic ability of lymphovascular invasion, perineural invasion, worst pattern of invasion, and depth of invasion to predict metastatic lymph node

Variables

Sensitivity

Specificity

Positive predictive value (PPV)

Negative predictive value (NPV)

Misclassification rate

Lymphovascular invasion

22.2%

95.5%

80.0%

62.5%

35.5%

Perineural invasion

13.0%

98.6%

87.5%

60.5%

37.8%

4 and 5 worst pattern of invasion (WPOI)

55.6%

67.1%

55.6%

67.1%

37.8%

Depth of invasion (DOI) 7.5 mm

72.2

50.7

52.0%

71.1%

40.2%

The sensitivity of LVI, PNI, DOI, and WPOI in predicting lymph nodal metastasis were 22.2, 13.0, 72.2, and 55.6%, while specificity of these were 95.5, 98.6, 50.7, and 67.1% with their misclassification rates as 35.5, 37.8, 40.2, and 37.8%, respectively.

ROC curve was used and an optimal cutoff for DOI was calculated as 7.50 mm with AUC as 0.610 (95% CI: 0.512–0.708). The sensitivity at this cutoff for DOI was 72.2% and the specificity was 50.7%, respectively. The PPV and NPV were 52.0 and 71.1% with misclassification rate as 40.2% (Table 4, Fig. 1).

Receiver operating characteristic curve (ROC) of depth of invasion to predict the likelihood of lymph node metastasis. Receiver operating characteristic (ROC) curve was used and an optimal cutoff for depth invasion was calculated as 7.50 mm with area under the curve as 0.610 (95% confidence interval [CI]: 0.512–0.708). The sensitivity at this cutoff for depth of invasion was 72.2% and the specificity was 50.7%, respectively. The positive predictive value (PPV) and negative predictive value (NPV) was 52.0 and 71.1% with misclassification rate as 40.2% (Table 4, Fig. 1).
Fig. 1: Receiver operating characteristic curve (ROC) of depth of invasion to predict the likelihood of lymph node metastasis. Receiver operating characteristic (ROC) curve was used and an optimal cutoff for depth invasion was calculated as 7.50 mm with area under the curve as 0.610 (95% confidence interval [CI]: 0.512–0.708). The sensitivity at this cutoff for depth of invasion was 72.2% and the specificity was 50.7%, respectively. The positive predictive value (PPV) and negative predictive value (NPV) was 52.0 and 71.1% with misclassification rate as 40.2% (Table 4, Fig. 1).

Using multivariable logistic model, the predicted probabilities for the presence of metastatic lymph node using four clinical parameters, that is, LVI, PNI, WPOI, and DOI, were computed after testing the model fit. The Hosmer–Lemeshow goodness of fit test produced a p-value of 0.687 which suggests that the model had a good fit. The AUC of the predicted probabilities for the logistic regression model was 0.713 which was statistically significant (p < 0.001) as shown in Fig. 2.

Receiver operating characteristic (ROC) curve of the logistic regression model.
Fig. 2: Receiver operating characteristic (ROC) curve of the logistic regression model.

The predicted probabilities for 16 possible combinations of LVI, PNI, WPOI, and DOI were obtained. The high, medium, and low risks for the presence of metastatic lymph node are shown in boxes with orange, blue, and yellow colors in Table 4. When LVI and PNI are present with DOI more than 7.5 mm and WPOI is 4 and 5, the predicted probability of lymph nodal metastasis is 0.97. When LVI and PNI are present with DOI less than 7.5 mm and WPOI is 4 and 5, the predicted probability of lymph nodal metastasis is 0.78. When LVI is absent and PNI is present with DOI more than 7.5 mm and WPOI is 1, 2, and 3, the predicted probability of lymph nodal metastasis is 0.75. When LVI is absent and PNI is present with DOI less than 7.5 mm and WPOI is 4 and 5, the predicted probability of lymph nodal metastasis is 0.78. When LVI is absent and PNI is present with DOI more than 7.5 mm and WPOI is 4 and 5, the predicted probability of lymph nodal metastasis is 0.86. When LVI is present and PNI is absent with DOI more than 7.5 mm and WPOI is 4 and 5, the predicted probability of lymph nodal metastasis is 0.83. These were high risk for cervical lymph nodal metastasis.

When LVI and PNI are present with DOI more than 7.5 mm and WPOI is 1, 2, and 3, the predicted probability of lymph nodal metastasis is 0.70. When LVI and PNI are present with DOI less than 7.5 mm and WPOI is 1, 2, and 3, the predicted probability of lymph nodal metastasis is 0.64. When LVI is absent and PNI is present with DOI less than 7.5 mm and WPOI is 1, 2, and 3, the predicted probability of lymph nodal metastasis is 0.64. When LVI is present and PNI is absent with DOI less than 7.5 mm and WPOI is 4 and 5, the predicted probability of lymph nodal metastasis is 0.74. When LVI is present and PNI is absent with DOI more than 7.5 mm and WPOI is 1, 2, and 3, the predicted probability of lymph nodal metastasis is 0.70. When LVI is present and PNI is absent with DOI less than 7.5 mm and WPOI is 1, 2, and 3, the predicted probability of lymph nodal metastasis is 0.58. When LVI and PNI are absent with DOI more than 7.5 mm and WPOI is 4 and 5, the predicted probability of lymph nodal metastasis is 0.50. These were medium-risk group.

When LVI and PNI are absent with DOI less than 7.5 mm and WPOI is 4 and 5, the predicted probability of lymph nodal metastasis is 0.38. When LVI and PNI are absent with DOI more than 7.5 mm and WPOI is 1, 2, and 3, the predicted probability of lymph nodal metastasis is 0.33. When LVI and PNI are absent with DOI less than 7.5 mm and WPOI is 1, 2, and 3, the predicted probability of lymph nodal metastasis is 0.23. These were low-risk group.

<insert Table 4 here>

Table 4
Predicted probability for metastasis lymph node with other risk factors

WPOI and DOI

Lymphovascular invasion and perineural invasion

Lymphovascular invasion and perineural invasion present

Lymphovascular invasion absent and perineural invasion present

Lymphovascular invasion present and perineural invasion absent

Lymphovascular invasion and perineural invasion absent

WPOI 4 and 5, DOI > 7.50 mm

0.97

0.86

0.83

0.50

WPOI 4 and 5, DOI < 7.50 mm

0.78

0.78

0.74

0.38

WPOI 1, 2, and 3, DOI > 7.50 mm

0.70

0.75

0.70

0.33

WPOI 1, 2, and 3, DOI < 7.50 mm

0.64

0.64

0.58

0.23

Abbreviations: DOI, depth of invasion; WPOI, worst pattern of invasion.

Note: Color codes: Yellow = probability < 0.50 (low risk of presence of metastatic lymph node), blue = probability between 0.50 and 0.70 (medium risk of presence of metastatic lymph node), orange = probability ≥ 0.75 (high risk of presence of metastatic lymph node).

A nomogram combining the significant risk factors was created to predict the likelihood of having a lymph node metastasis based on the results obtained from the logistic regression analysis (Fig. 3). The nomogram had seven rows in total. The factors are listed in the first four rows, and each variable has a weighted point total that predicts lymph node metastasis. For instance, LVI was related with 0 points when it was not present but with 5.5 points when it was present. Row 5 displays the score for each variable, while row 7 displays the overall score. Each score may be added up to produce a total score, which would then be plotted on the scale axis for total scores. The probability of risk of lymph node metastasis for specific individuals may then be determined using this total score by drawing a straight line from the scale axis (row 6) at the bottom of Fig. 3. Out of 127 study population, 73 did not have cervical lymph nodal metastasis and 54 had cervical lymph nodal metastasis. With respect to our nomogram score, less than 10 were seen in 28 (80%) patients who did not have cervical lymph nodal metastasis and 7 (20%) who had cervical lymph nodal metastasis. Scores between 11 and 15, 42 (57.5%) with no cervical lymph nodal metastasis and 31 (42.5%) for those who had cervical lymph nodal metastasis. Between scores 16 and 20, 3 (18.8%) with no cervical lymph nodal metastasis and 13 (81.2%) people had cervical lymph nodal metastasis. When the score was over 20, our study population had only 3 patients. All had cervical lymph nodal metastasis. Also, the scoring system has been explored to find the optimal cutoff value (11.5) for predicting the metastasis lymph node based on the total scores got for each patient from a nomogram. The AUC with 95% CI was 0.713 (0.62–0.80) which was statistically significant (p < 0.001). The sensitivity and specificity were around 66.7 and 64.4%.

Nomogram predicting the likelihood of lymph node metastasis.
Fig. 3: Nomogram predicting the likelihood of lymph node metastasis.

<insert Table 5 here>

Table 5
Nomogram score distribution

Nomogram score distribution

Nonmetastatic lymph node

Metastatic lymph node

Total

< 10

28 (80.0%)

7 (20.0%)

35

11–15

42 (57.5%)

31 (42.5%)

73

16–20

3 (18.8%)

13 (81.2%)

16

> 20

0 (0.0%)

3 (100%)

3

Total

73 (57.5%)

54 (42.5%)

127

Discussion

Cervical nodal metastasis is the most important prognostic factor in oral squamous cell carcinoma (OSCC), and accurate prediction is required so that appropriate radical surgery can be done.

Even after doing preop CT scan ± MRI and supplemented with USG-guided FNAC in CN0 neck, sentinel lymph node biopsy was positive in 23% for malignancy according to the SENT trial.6 Horváth et al did a study to find sensitivity of different imaging modalities for cervical lymph node metastasis in clinically N0 neck, none of these methods can definitively exclude the presence of regional tumor metastasis.7

In our study using the following parameters LVI, PNI, WPOI, and DOI we have created nomogram for prediction of lymph nodal metastasis.

Huang et al did a meta-analysis and found LVI positivity in OSCC was associated with lymph nodal metastasis and worse overall survival.8

Quintana et al did a systematic review and found PNI positivity in OSCC was associated increased lymph nodal metastasis, risk of recurrence, and reduced survival.9

<insert Table 6 here>

Table 6
Univariate analysis, sensitivity, and specificity of individual parameters with lymph node metastasis of different studies

Paper

Chen et al13

Arora et al10

De Silva et al14

Our study

Only buccal mucosa

Site

Buccal mucosa

All subsites

Tongue and buccal mucosa

Univariate

Univariate

Sensitivity

Specificity

Univariate

Univariate

Sensitivity

Specificity

Gender

0.454

ND

ND

ND

ND

0.028

ND

ND

Age

0.003

NA

ND

ND

0.50

ND

ND

ND

T stage

0.001

0.0371

ND

ND

< 0.1

0.139

ND

ND

Tumor thickness

0.001

0.9753

ND

ND

ND

ND

ND

ND

Tumor differentiation

0.004

0.0003

82%

81%

ND

ND

ND

ND

Tumor budding

ND

0.0089

69%

63%

ND

ND

ND

ND

DOI

ND

< 0.0001

92%

91%

< 0.1

0.010

72.2%

50.7%

Shape of nest

ND

0.0276

ND

ND

ND

ND

Lymphoid response

ND

0.0012

71%

68%

ND

ND

ND

ND

WPOI

ND

< 0.0001

87%

86%

< 0.1

0.011

55.6%

67.1%

Eosinophilic infiltration

ND

0.4446

ND

ND

ND

ND

ND

ND

LVI

ND

0.0008

80%

74%

ND

0.005

22.2%

95.2%

PNI

ND

0.0002

85%

83%

ND

0.029

13%

98.6%

Abbreviations: DOI, depth of invasion; LVI, lymphovascular invasion; ND, not done; PNI, perineural invasion; WPOI, worst pattern of invasion.

Arora et al developed a model in predicting the lymph nodal metastasis in early oral cavity squamous cell carcinoma, using DOI, WPOI, PNI, grade of tumor, LVI, lymphoid response, and tumor budding with scores ranging from 7 to 11, 12 to 16, and ≥ 17 points showing lymph nodal metastasis in 6.4, 22.8, and 77.1% of cases, respectively,10 but in our study, we have developed nomogram using DOI, WPOI, PNI, and LVI and scoring ranging less than 10, 11 to 15, 16 to 20, and more than 20, the predicted lymph nodal metastasis is 20, 42.5, 81.2, and 100%, respectively.

Chatterjee et al conducted a study that showed that the WPOI, tumor budding, PNI, and LVI are important markers in predicting lymph nodal metastasis in early buccal mucosa cancer,11 on comparing to our study the p-value was significant in WPOI, LVI, and PNI in prediction of lymph nodal metastasis, but we did not study about tumor budding in our study.

Shah and Parikh showed that DOI was associated with the prediction of lymph nodal metastasis in the tongue above 8 mm is 75% and buccal mucosa above 10 mm is 66.66%,12 in comparison with our studies it was > 7.5 mm with 72.2%.

Chen et al constructed a nomogram by using age (p = 0.004), tumor thickness (p = 0.002), tumor differentiation (p = 0.027), and clinical nodal (p = 0.001) status and showed lymph nodal metastasis can be predicted preoperatively in buccal mucosa cancer.13

De Silva et al constructed a model that predicts lymph nodal metastasis using DOI, WPOI, and tumor stage in buccal mucosa cancer and the model revealed that T4 tumors in the buccal mucosa that have POI type 3 and has a DOI > 4 mm are more likely to metastasize. It also showed that T3 and T4 tumors in the buccal mucosa with POI type 4 tend to metastasize regardless of its DOI.14

Our nomogram has four parameters that show accuracy in the prediction of lymph nodal metastasis in buccal mucosa cancer, any score of more than 11.5 has high chance of lymph nodal metastasis. The main advantage of our study is to find predictor of lymph nodal metastasis in buccal mucosa cancer with routine histopathological parameters that can help us to guide for extent of neck dissection, adjuvant treatment, and prognostication of the patient. When edge wedge biopsy is done preoperatively it helps us determine accurately LVI, PNI, and WPOI. DOI can be found radiologically. Using the histological and radiological parameter we can predict the lymph nodal metastasis in buccal mucosa cancer preoperatively. Mukherjee et al showed that they were able to find LVI and PNI radiologically using a radiomics-based CT scan.15 Wang et al showed DOI can be preoperatively measured radiologically.16 The future study plan can be incorporating radiological and small biopsy parameters in predicting the lymph nodal metastasis using our nomogram.

Conclusion

This study proposes a simple predictive model for the risk of lymph nodal metastasis in buccal mucosa squamous cell cancer. However, the study has strength that, it is based on a large sample size, proposed model being simple, and based on parameters empirically supported as well as established in literature. It is easy to use in routine clinical practice and cost-effective. Although findings of this retrospective study need further validation in a prospective study, it provides a useful model that is practical to use in developing countries of South and Southeast Asia where OSCC etiology is similar and advanced facilities are not available.

Recommendation

  • (1) In patient where nomogram score is more than 10 we recommend for modified neck dissection as predicting probability of cervical lymph nodal metastasis is 42.5%.

  • (2) In patient where nomogram score is less than 10 we recommend for selective neck dissection as predicting probability of cervical lymph nodal metastasis is 20%.

  • (3) A large cohort prospective study is warranted.

References

  1. , , , et al . Oral cancer prevalence in Western population of Maharashtra, India, for a period of 5 years. Journal of Oral Research and Review. 2018;10(01):11-14.
    [Google Scholar]
  2. , , , et al . The Eighth Edition AJCC Cancer Staging Manual: continuing to build a bridge from a population-based to a more “personalized” approach to cancer staging. CA Cancer J Clin. 2017;67(02):93-99.
    [Google Scholar]
  3. , , , et al . Sentinel lymph node biopsy for oral squamous cell carcinoma. Where are we now? Br J Oral Maxillofac Surg. 2017;55(08):757-762.
    [Google Scholar]
  4. , , , et al , . Elective versus therapeutic neck dissection in node-negative oral cancer. N Engl J Med. 2015;373(06):521-529.
    [Google Scholar]
  5. , , , , . Lymph node metastasis: a bearing on prognosis in squamous cell carcinoma. Indian J Cancer. 2015;52(03):417-424.
    [Google Scholar]
  6. , , , et al . Sentinel European Node Trial (SENT): 3-year results of sentinel node biopsy in oral cancer. Eur J Cancer. 2015;51(18):2777-2784.
    [Google Scholar]
  7. , , , , , , . Accuracy of the preoperative diagnostic workup in patients with head and neck cancers undergoing neck dissection in terms of nodal metastases. Eur Arch Otorhinolaryngol. 2021;278(06):2041-2046.
    [Google Scholar]
  8. , , , , , . Impact of lymphovascular invasion in oral squamous cell carcinoma: a meta-analysis. Oral Surg Oral Med Oral Pathol Oral Radiol. 2021;131(03):319-328.e1.
    [Google Scholar]
  9. , , , . Prognostic impact of perineural invasion in oral cancer: a systematic review. Acta Otorhinolaryngol Ital. 2022;42(01):17-25.
    [Google Scholar]
  10. , , , et al . Development of a new outcome prediction model in early-stage squamous cell carcinoma of the oral cavity based on histopathologic parameters with multivariate analysis. Am J Surg Pathol. 2017;41(07):950-960.
    [Google Scholar]
  11. , , , et al . Tumor budding and worse pattern of invasion can predict nodal metastasis in oral cancers and associated with poor survival in early-stage tumors. Ear Nose Throat J. 2019;98(07):E112-E119.
    [Google Scholar]
  12. , , . Clinicopathological correlation between depth of tumor and neck node metastasis in oral (tongue and buccal mucosa) carcinoma. Int J Head Neck Surg. 2021;12(01):6-10.
    [Google Scholar]
  13. , , , . A preoperative nomogram model for the prediction of lymph node metastasis in buccal mucosa cancer. Cancer Med. 2023;12(13):14120-14129.
    [Google Scholar]
  14. , , , , , . A model to predict nodal metastasis in patients with oral squamous cell carcinoma. PLoS One. 2018;13(08):e0201755.
    [Google Scholar]
  15. , , , et al . CT-based radiomic signatures for predicting histopathologic features in head and neck squamous cell carcinoma. Radiol Imaging Cancer. 2020;2(03):e190039.
    [Google Scholar]
  16. , , , et al . Magnetic resonance imaging-based radiomics features associated with depth of invasion predicted lymph node metastasis and prognosis in tongue cancer. J Magn Reson Imaging. 2022;56(01):196-209.
    [Google Scholar]
Show Sections